Navigation Links
Cord Blood Registry Supports Introduction of the Cord Blood Education and Awareness Act of 2009
Date:4/29/2009

Landmark Bill to Advance Education and Informed Consent Recommendations Established by the Institutes of Medicine

SAN BRUNO, Calif., April 29 /PRNewswire/ -- Cord Blood Registry (CBR), the global leader in the collection and preservation of newborn stem cells from umbilical cord blood, announced its support of legislation introduced by Congresswoman Jackie Speier (D-CA) entitled the "Cord Blood Education and Awareness Act of 2009." If passed, this ground-breaking legislation will require the Secretary of Health and Human Services to develop and disseminate public education materials that will educate patients and physicians on the value of umbilical cord blood stem cells and set standards for patients to document the choice they've made about banking their newborn's cord blood stem cells. The Institutes of Medicine introduced recommendations on informed choice about cord blood banking in a comprehensive study submitted to Congress in 2004.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090326/SF89756LOGO)

"Throughout her distinguished career, Congresswoman Speier has been a champion for women's and children's health issues, and we are pleased to see a legislator of her stature and experience recognize the need for public education on the value of newborn stem cells," said David Zitlow, senior vice president of public affairs for CBR. "As a California legislator she introduced the Maternal Child & Health Advancement Act, which became one of the first state laws to focus attention on the importance of educating every expectant parent about cord blood stem cells."

Umbilical cord blood is a rich and diverse source of newborn stem cells that can be collected without ethical concerns in a ten minute window immediately after birth. Newborn stem cells have been used for during the last 20 years to treat life-threatening cancers like leukemia and lymphoma, as well as immune system deficiencies and blood disorders, such as sickle cell anemia.

Additionally, this population of stem cells is increasingly a sought-after source for clinical research in regenerative medicine because these cells have demonstrated embryonic-like capabilities to proliferate and develop into all of the major cell types in the body -- without tumor or immune response issues. Regenerative therapies using newborn stem cells from cord blood are being evaluated for conditions including traumatic brain injury, cerebral palsy, stroke, type 1 diabetes, heart disorders and hearing loss.

In addition to the creation of a patient education campaign, Rep. Speier's legislation provides for the development of materials to focus on educating maternal health care providers. A study published in the Journal of Reproductive Health found that more than 90 percent of patients with some familiarity about cord blood banking had an expectation that their obstetricians would be able to provide information on this subject.

Further, the Cord Blood Education and Empowerment Act requires the Department of Health and Human Services to develop a standardized document and process for health care professionals to obtain written acknowledgement from patients - also called informed consent -that confirms they have received education on cord blood banking options and records their decision. Because the availability of these cells may have implications for future health treatment decisions, this provision will provide additional support for parents to make a more informed decision.

"With this legislation, Rep. Speier has set forth a national health policy framework that will help save more lives," said Zitlow. "By empowering physicians and patients with new resources, this legislation will help maximize access to and availability of newborn stem cells for patient care and medical research."

About Cord Blood Registry

Cord Blood Registry(R) (CBR(R)) is the world's largest stem cell bank, focused on the collection, processing and storage of newborn stem cells from umbilical cord blood and ensuring their viability for medical use. CBR is the most recommended family cord blood bank by obstetricians and was the first family bank accredited by AABB (formerly the American Association of Blood Banks). The company has been profitable and cash flow positive from operations on a cumulative basis since 1999. To date, CBR has processed and stored cord blood units for more than 260,000 newborns from around the world and has released more client cord blood units for specific therapeutic use than any other family cord blood bank. The company's research and development efforts are focused on helping the world's leading clinical researchers advance regenerative medical therapies using cord blood stem cells as well as enhancing its industry-leading technical innovations for stem cell collection, processing and storage that optimize quality and cell yield. For more information, visit www.CordBlood.com.


'/>"/>
SOURCE Cord Blood Registry
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WA discovery a key to blood cell development
2. Simple blood test proves powerful ally in the fight against malaria
3. New target for maintaining healthy blood pressure discovered
4. Drug inhibits neuroblastoma blood supply in pre-clinical tests
5. Roche Announces New Co-pay Program in Pennsylvania that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
6. Roche Announces New Co-pay Program in Florida that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
7. Roche Announces New Co-Pay Program in California That Makes it Easier for Patients With Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
8. UBC research finds molecular "key" to successful blood stem cell transplants
9. Test for hormones in blood not reflective of hormones in breast tissue; breast cancer risk
10. Blood transfusions and outcomes
11. Blood Transfusion and Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... SignatureCare Emergency Center ... be awarded for the fall semester to a deserving student. Get your applications ... 2017 scholarship was awarded to Mariana Castillo who is a nursing student at Prairie ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... (MCPS) have partnered together for a unique opportunity that helps high school girls succeed ... “Removing Barriers, Creating Opportunities.” Horizon Goodwill will host over 20 high school ...
(Date:7/24/2017)... , ... July 24, 2017 , ... The International Essential ... life-altering neurological condition called essential tremor (ET). The seminar will take place on Saturday, ... Woods Blvd., Independence, OH. The program will run from 9 a.m. to 12 p.m., ...
(Date:7/24/2017)... ... July 24, 2017 , ... The Topricin Companies, ... awareness for Topricin’s revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. ... of long term skin conditions, including cancer. In the short term, overexposure ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the global ... the issuance of United States Patent Number 9,695,398 (the '398 patent) and South ... The '398 and '324 patents cover methods and systems for optimizing fat grafts ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) announced ... operating results on Monday, August 7, 2017 after market ... p.m. ET. Shareholders ... of the conference call by dialing 877-201-0168 or 647-788-4901 ... 15 minutes prior to the call. A live webcast ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 ... ) announced today that it will report its second ... Thursday, July 27, 2017. ... July 27, 2017, at 9:00 a.m. Eastern Time.  The ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will be ...
(Date:7/21/2017)... you know that PhRMA member companies invested $65.5 billion in research ... medicines, generics and the supply chain account for 14 percent of ... this (7 percent)? Or that the United States ... in high-growth biopharmaceutical startups? ... The biopharmaceutical industry accounts for ...
Breaking Medicine Technology: